The new Schedule M will be implemented from 1 January, 2026, to help MSMEs adjust to updated manufacturing standards.

The Health Ministry has extended the deadline by 12 months for small and medium pharma companies to comply with revised good ...

The regulatory basis and compliance examples from FDA observations and warning letters are included to support the need for an effective process. The Center for Drug Evaluation and Research’s new ...

In a significant step toward ensuring global quality standards, Indian pharmaceutical, nutraceutical, and medical device ...

Quality compliance in the pharma industry is foundational to guaranteeing safe and effective products. For years, Good ...

Barlowe Herbal Elixirs invests in InstantGMP PRO to streamline GMP compliance with advanced software for batch records, inventory, and quality management. Known for their dedication to crafting ...

The Health Ministry extends the deadline for MSME pharma companies to comply with Schedule M regulations until December 31, 2025.

India's Health Ministry grants MSME pharma companies an additional year to meet revised GMP standards under Schedule M, ...

Pet2DAO, our DAO Company was established in late 2022 and launched its token, PDAO, in early 2023. PDAO was launched as a utility token, integrating traditional corporate governance with innovative ...

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property ...

"Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Medicines and Healthcare products ...